-
Planet TV Studios Unveils New 'New Frontiers' Episode Featuring NeOnc Technologies Holdings, Inc., Airing Q1 2025
30 Jan 2025 21:34 GMT
… conditions like glioblastoma multiforme and metastatic brain tumors, potentially offering hope where traditional …
-
The ADC OQY-3258 Demonstrates Early Efficacy in Multiple Breast Cancer Subtypes
31 Jan 2025 00:21 GMT
… that patients with efficacy-evaluable brain metastases and HER2-negative disease treated … -negative metastatic breast cancer with brain metastases. Ann Oncol. 2024;35(suppl …
-
World first: Delivering chemotherapy to paediatric brain tumours using MRI-guided focused ultrasound
30 Jan 2025 23:46 GMT
… the blood brain barrier in brain metastases.
Sunnybrook has also continued this …
-
Kazia Therapeutics Announces The Launch Of A Groundbreaking Trial With Paxalisib In Combination With Immunotherapy In Women With Advanced Breast Cancer
30 Jan 2025 13:27 GMT
… involving paxalisib are ongoing in brain metastases, diffuse midline gliomas, and primary … the treatment of solid tumour brain metastases harboring PI3K pathway mutations in …
-
Why late-stage breast cancer patients should receive routine brain MRI screening
30 Jan 2025 13:06 GMT
… receive early treatment for their brain metastases, including changes in systemic therapy …
-
Response Time and BRAF Status Factor Into IO Selection for Melanoma
30 Jan 2025 05:17 GMT
… ;relatlimab trial excluded patients with brain metastases, and brain metastases are not uncommon with …
-
ASX Quarterly Health Wrap: Bioxyne revenue up 77%, Radiopharm lists on Nasdaq
30 Jan 2025 03:41 GMT
… Phase 2b imaging trial targeting brain metastases.
Radiopharm also inked a strategic …
-
REZILIENT1 Study of Zipalertinib in Pretreated EGFR-Mutant NSCLC Meets ORR Primary End Point
29 Jan 2025 21:17 GMT
… ; those with stable or asymptomatic brain metastases were permitted. All patients in …
-
Vincerx Pharma, Inc. and Oqory, Inc. Highlight Promising Data for Oqory’s TROP2 Antibody Drug Conjugate, OQY-3258
29 Jan 2025 13:00 GMT
… meaningful activity in patients with brain metastases, reporting an intracranial ORR of … responses. Additionally, in patients with brain metastases, PFS (95% confidence interval) was …
-
Moffitt Research Advocates for Routine Brain MRI Screening in Asymptomatic Late Stage Breast Cancer Patients
29 Jan 2025 04:12 GMT
… receive early treatment for their brain metastases, including changes in systemic therapy …